IL-2: efficacy in renal cell carcinoma and overall safety profile.
Louie
A
A
Cetus Corporation, Emeryville, California 94608-2997.
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*
D007376:Interleukin-2